Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum

International Journal of Medical Microbiology

Volumn 305, Issue 1, 2015, Pages 1-10

  Kolpen, Mette ^a,b   Kragh, Kasper Nørskov ^b   Bjarnsholt, Thomas ^a,b   Line, Laura ^a   Hansen, Christine Rønne ^a   Dalbøge, Christina Schjellerup ^a   Hansen, Nana ^c   Kühl, Michael ^c,d,e   Høiby, Niels ^a,b   Jensen, Peter Østrup ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Achromobacter xylosoxidans; Burkholderia multivorans and stenotrophomonas maltophilia; Cystic fibrosis; Denitrification; N2O; Pseudomonas aeruginosa

Indexed keywords

NITRITE REDUCTASE; NITROUS OXIDE; RNA 16S;

ACHROMOBACTER XYLOSOXIDANS; ADULT; ANAEROBIC GROWTH; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIUM DETECTION; BACTERIUM ISOLATE; BURKHOLDERIA MULTIVORANS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DENITRIFICATION; DISEASE DURATION; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; LUNG FIBROSIS; MALE; MICROBIAL BIOMASS; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; SPUTUM; STENOTROPHOMONAS MALTOPHILIA;

EID: 84940166964     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2014.07.002     Document Type: Article

References (73)

1. Aaron S.D., Ferris W., Ramotar K., Vandemheen K., Chan F., Saginur R. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J. Clin. Microbiol. 2002, 40:4172-4179.
2. Andersen K., Kjær T., Revsbech N.P. An oxygen insensitive microsensor for nitrous oxide. Sens. Actuators B Chem. 2001, 81:42-48.
3. Cystic Fibrosis Foundation Patient Registry Annual Data Report, 2010 2011, Cystic Fibrosis Foundation, Bethesda, MD.
4. ECFS Patient Registry Annual Data Report, 2008-2009 data 2012, European Cystic Fibrosis Society, Karup, Denmark.
5. UK CF Registry Annual Data Report, 2010 2012, Cystic Fibrosis Trust, Bromley, Kent, UK.
6. Arai H., Iiyama K. Role of nitric oxide-detoxifying enzymes in the virulence of Pseudomonas aeruginosa against the silkworm, Bombyx mori. Biosci. Biotechnol. Biochem. 2013, 77:198-200.
7. Arai H., Sanbongi Y., Igarashi Y., Kodama T. Cloning and sequencing of the gene encoding cytochrome c-551 from Pseudomonas aeruginosa. FEBS Lett. 1990, 261:196-198.
8. Baler K., Landini G., Rasband W. MultiTresholder 2009.
9. Baltimore R.S., Christie C.D., Smith G.J. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am. Rev. Respir. Dis. 1989, 140:1650-1661.
10. Bjarnsholt T., Jensen P.Ø., Fiandaca M.J., Pedersen J., Hansen C.R., Andersen C.B., Pressler T., Givskov M., Høiby N. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 2009, 44:547-558.
11. Borriello G., Werner E., Roe F., Kim A.M., Ehrlich G.D., Stewart P.S. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 2004, 48:2659-2664.
12. Boucher R.C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 2007, 261:5-16.
13. Burns J.L., Emerson J., Stapp J.R., Yim D.L., Krzewinski J., Louden L., Ramsey B.W., Clausen C.R. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 1998, 27:158-163.
14. Chen F., Xia Q., Ju L.K. Aerobic denitrification of Pseudomonas aeruginosa monitored by online NAD(P)H fluorescence. Appl. Environ. Microbiol. 2003, 69:6715-6722.
15. Ciofu O., Hansen C.R., Høiby N. Respiratory bacterial infections in cystic fibrosis. Curr. Opin. Pulm. Med. 2013, 19:251-258.
16. Crossman L.C., Gould V.C., Dow J.M., Vernikos G.S., Okazaki A., Sebaihia M., Saunders D., Arrowsmith C., Carver T., Peters N., Adlem E., Kerhornou A., Lord A., Murphy L., Seeger K., Squares R., Rutter S., Quail M.A., Rajandream M.A., Harris D., Churcher C., Bentley S.D., Parkhill J., Thomson N.R., Avison M.B. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008, 9:R74. 10.1186/gb-2008-9-4-r74.
17. Dalbøge C.S., Hansen C.R., Pressler T., Høiby N., Johansen H.K. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. J. Cyst. Fibros. 2011, 10:318-325.
18. Drevinek P., Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin. Microbiol. Infect. 2010, 16:821-830.
19. Eschbach M., Schreiber K., Trunk K., Buer J., Jahn D., Schobert M. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 2004, 186:4596-4604.
20. Gaston B., Ratjen F., Vaughan J.W., Malhotra N.R., Canady R.G., Snyder A.H., Hunt J.F., Gaertig S., Goldberg J.B. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am. J. Respir. Crit. Care Med. 2002, 165:387-390.
21. Grasemann H., Ioannidis I., Tomkiewicz R.P., de Groot H., Rubin B.K., Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch. Dis. Child. 1998, 78:49-53.
22. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.Ø., Bjarnsholt T., Høiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010, 9:51-58.
23. Hansen N., Rasmussen A.K.I., Fiandaca M.J., Kragh K.N., Bjarnsholt T., Høiby N., Stender H., Guardabassi L. Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization. New Microbe. New Infect. 2014, 2:79-81.
24. Hassett D.J. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J. Bacteriol. 1996, 178:7322-7325.
25. Hoboth C., Hoffmann R., Eichner A., Henke C., Schmoldt S., Imhof A., Heesemann J., Hogardt M. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 2009, 200:118-130.
26. Hoffman L.R., Kulasekara H.D., Emerson J., Houston L.S., Burns J.L., Ramsey B.W., Miller S.I. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J. Cyst. Fibros. 2009, 8:66-70.
27. Hoffman L.R., Richardson A.R., Houston L.S., Kulasekara H.D., Martens-Habbena W., Klausen M., Burns J.L., Stahl D.A., Hassett D.J. Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog. 2010, 6:e1000712.
28. Høiby N. Microbiology of cystic fibrosis. Cystic Fibrosis 2000, 83-107. Arnold, London, UK. G.D. Hodson, M.E. (Eds.).
29. Jakobsen T.H., Hansen M.A., Jensen P.Ø., Hansen L., Riber L., Cockburn A., Kolpen M., Rønne Hansen C., Ridderberg W., Eickhardt S., Hansen M., Kerpedjiev P., Alhede M., Qvortrup K., Burmølle M., Moser C., Kühl M., Ciofu O., Givskov M., Sørensen S.J., Høiby N., Bjarnsholt T. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes. PLOS ONE 2013, 8:e68484.
30. Jensen P.Ø., Moser C., Kharazmi A., Presler T., Koch C., Høiby N. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. J. Cyst. Fibros. 2006, 5:145-151.
31. John P., Whatley F.R. Oxidative phosphorylation coupled to oxygen uptake and nitrate reduction in Micrococcus denitrificans. Biochim. Biophys. Acta 1970, 216:342-352.
32. Jones K.L., Hegab A.H., Hillman B.C., Simpson K.L., Jinkins P.A., Grisham M.B., Owens M.W., Sato E., Robbins R.A. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr. Pulmonol. 2000, 30:79-85.
33. Kakishima K., Shiratsuchi A., Taoka A., Nakanishi Y., Fukumori Y. Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages. Biochem. Biophys. Res. Commun. 2007, 355:587-591.
34. Kawasaki S., Arai H., Igarashi Y., Kodama T. Sequencing and characterization of the downstream region of the genes encoding nitrite reductase and cytochrome c-551 (nirSM) from Pseudomonas aeruginosa: identification of the gene necessary for biosynthesis of heme d1. Gene 1995, 167:87-91.
35. Kawasaki S., Arai H., Kodama T., Igarashi Y. Gene cluster for dissimilatory nitrite reductase (nir) from Pseudomonas aeruginosa: sequencing and identification of a locus for heme d1 biosynthesis. J. Bacteriol. 1997, 179:235-242.
36. Kimura A., Yuhara S., Ohtsubo Y., Nagata Y., Tsuda M. Suppression of pleiotropic phenotypes of a Burkholderia multivorans fur mutant by oxyR mutation. Microbiology 2012, 158:1284-1293.
37. Knowles M.R., Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 2002, 109:571-577.
38. Koike I., Hattori A. Energy yield of denitrification: an estimate from growth yield in continuous cultures of Pseudomonas denitrificans under nitrate-, nitrite- and oxide-limited conditions. J. Gen. Microbiol. 1975, 88:11-19.
39. Koike I., Hattori A. Growth yield of a denitrifying bacterium, Pseudomonas denitrificans, under aerobic and denitrifying conditions. J. Gen. Microbiol. 1975, 88:1-10.
40. Kolpen M., Hansen C.R., Bjarnsholt T., Moser C., Christensen L.D., van Gennip M., Ciofu O., Mandsberg L., Kharazmi A., Döring G., Givskov M., Høiby N., Jensen P.Ø. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 2010, 65:57-62.
41. Kolpen M., Bjarnsholt T., Moser C., Hansen C.R., Rickelt L.F., Kühl M., Hempel C., Pressler T., Høiby N., Jensen P.Ø. Nitric oxide production by polymorphonuclear leukocytes in infected cystic fibrosis sputum consumes oxygen. Clin. Exp. Immunol. 2014, 177:310-319.
42. Kolpen M., Kuhl M., Bjarnsholt T., Moser C., Hansen C.R., Liengaard L., Kharazmi A., Pressler T., Høiby N., Jensen P.Ø. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLOS ONE 2014, 9:e84353.
43. Kragh K.N., Alhede M., Jensen P.Ø., Moser C., Jacobsen C.S., Seier S., Eickhardt S., Trøstrup H., Christoffersen L., Hougen H., Givskov M., Kühl M., Høiby N., Bjarnsholt T. Infect. Immune. Polymorphonuclear Leukocytes Restrict the Growth of Pseudomonas aeruginosa in Lungs of Cystic Fibrosis Patients 2014, Accepted.
44. Linnane S.J., Keatings V.M., Costello C.M., Moynihan J.B., O'Connor C.M., Fitzgerald M.X., McLoughlin P. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am. J. Respir. Crit. Care Med. 1998, 158:207-212.
45. Major T.A., Panmanee W., Mortensen J.E., Gray L.D., Hoglen N., Hassett D.J. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother. 2010, 54:4671-4677.
46. Palmer K.L., Brown S.A., Whiteley M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 2007, 189:4449-4455.
47. Pessi G., Braunwalder R., Grunau A., Omasits U., Ahrens C.H., Eberl L. Response of Burkholderia cenocepacia H111 to micro-oxia. PLOS ONE 2013, 8:e72939.
48. Philippot L. Denitrifying genes in bacterial and Archaeal genomes. Biochim. Biophys. Acta 2002, 1577:355-376.
49. Philippot L. Denitrification in pathogenic bacteria: for better or worst?. Trends Microbiol. 2005, 13:191-192.
50. Pompilio A., Crocetta V., Confalone P., Nicoletti M., Petrucca A., Guarnieri S., Fiscarelli E., Savini V., Piccolomini R., Di Bonaventura G. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 2010, 10:102.
51. Proctor R.A., von Eiff C., Kahl B.C., Becker K., McNamara P., Herrmann M., Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 2006, 4:295-305.
52. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., Drumm M.L., Iannuzzi M.C., Collins F.S., Tsui L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066-1073.
53. Rønne H.C., Pressler T., Høiby N., Gormsen M. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. J. Cyst. Fibros. 2006, 5:245-251.
54. Sass A.M., Schmerk C., Agnoli K., Norville P.J., Eberl L., Valvano M.A., Mahenthiralingam E. The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia. ISME J. 2013, 7:1568-1581.
55. Silva I.N., Ferreira A.S., Becker J.D., Zlosnik J.E., Speert D.P., He J., Mil-Homens D., Moreira L.M. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology 2011, 157:3124-3137.
56. Silvestrini M.C., Galeotti C.L., Gervais M., Schinina E., Barra D., Bossa F., Brunori M. Nitrite reductase from Pseudomonas aeruginosa: sequence of the gene and the protein. FEBS Lett. 1989, 254:33-38.
57. Sousa S.A., Ulrich M., Bragonzi A., Burke A., Worlitzsch D., Leitão J.H., Meisner C., Eberl L., Sá-Correia I., Döring G. Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice. Cell. Microbiol. 2007, 9:2817-2825.
58. Spicuzza L., Sciuto C., Vitaliti G., Di D.G., Leonardi S., La R.M. Emerging pathogens in cystic fibrosis: ten years of follow-up in a cohort of patients. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:191-195.
59. Strohm T.O., Griffin B., Zumft W.G., Schink B. Growth yields in bacterial denitrification and nitrate ammonification. Appl. Environ. Microbiol. 2007, 73:1420-1424.
60. Thauer R.K., Jungermann K., Decker K. Energy conservation in chemotrophic anaerobic bacteria. Bacteriol. Rev. 1977, 41:100-180.
61. Vander W.C., Pierard A., Kley-Raymann M., Haas D. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 1984, 160:928-934.
62. Waters V., Atenafu E.G., Lu A., Yau Y., Tullis E., Ratjen F. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J. Cyst. Fibros. 2013, 12:482-486.
63. Waters V.J., Gomez M.I., Soong G., Amin S., Ernst R.K., Prince A. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect. Immun. 2007, 75:1698-1703.
64. Weiss R.F., Price B.A. Nitrous oxide solubility in water and seawater. Mar. Chem. 1980, 8:347-359.
65. Williams D.R., Rowe J.J., Romero P., Eagon R.G. Denitrifying Pseudomonas aeruginosa: some parameters of growth and active transport. Appl. Environ. Microbiol. 1978, 36:257-263.
66. Woodard L.M., Bielkie A.R., Eisses J.F., Ketchum P.A. Occurrence of nitrate reductase and molybdopterin in Xanthomonas maltophilia. Appl. Environ. Microbiol. 1990, 56:3766-3771.
67. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Döring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109:317-325.
68. Yang L., Haagensen J.A., Jelsbak L., Johansen H.K., Sternberg C., Høiby N., Molin S. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 2008, 190:2767-2776.
69. Yoon S.S., Hennigan R.F., Hilliard G.M., Ochsner U.A., Parvativar K., Kamani M.C., Allen H.L., Dekievit T.R., Gardner P.R., Schwab U., Rowe J.J., Iglewski B.H., McDermot T.R., Mason R.P., Wozniak D.J., Hancock R.E., Parsek M.R., Noah T.L., Boucher R.C., Hassett D.J. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 2002, 3:593-603.
70. Yoon S.S., Coakley R., Lau G.W., Lymar S.V., Gaston B., Karabulut A.C., Hennigan R.F., Hwang S., Buettner G., Schurr M.J., Mortensen J.E., Burns J.L., Speert D., Boucher R.C., Hassett D.J. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 2006, 116:436-446.
71. Yuhara S., Komatsu H., Goto H., Ohtsubo Y., Nagata Y., Tsuda M. Pleiotropic roles of iron-responsive transcriptional regulator Fur in Burkholderia multivorans. Microbiology 2008, 154:1763-1774.
72. Zumft W.G. Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 1997, 61:533-616.
73. Zumft W.G. Nitric oxide reductases of prokaryotes with emphasis on the respiratory, heme-copper oxidase type. J. Inorg. Biochem. 2005, 99:194-215.